Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-01

Clinical Trial Update: AZD2171 to Treat Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AZD2171 in prostate cancer, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD2171 (cediranib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-07-01